NPM1A in Plasma is a Potential Prognostic Biomarker in Acute Myeloid Leukemia

OBJECTIVE: The aim of the study was to investigate whether nucleophosmin type A mutation (NPM1A) in plasma was associated with the prognosis of patients with acute myeloid leukemia (AML). METHODS: Plasma NPM1A levels were investigated in 80 AML patients, 22 patients with benign hematopathy and 12 he...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Life Sci
Main Authors: Sun, Chengming, Gao, Yujie, Yang, Liping, Shao, Huiyuan, li, Jie, Gao, Xuejun, Ma, Li, Lin, Mingming, Sui, Jingrui
Formato: Artigo
Idioma:Inglês
Publicado em: De Gruyter 2018
Assuntos:
Topical Issue on Precision Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7874735/
https://ncbi.nlm.nih.gov/pubmed/33817088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/biol-2018-0028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados